Downregulation of SLC44A4 in nasopharyngeal carcinoma is associated with malignant progression, B-cell/TLS-related immune features, and sensitivity to DNA-damaging agents
Qian Liu, Yiyue Yin, Guangxian Hu, Hongde Li, Min Li, Xiangjian Luo, Wenbin Liu · 2026
Read Downregulation of SLC44A4 in nasopharyngeal carcinoma is associated with malignant progression, B-cell/TLS-related immune features, and sensitivity to DNA-damaging agents by Qian Liu, Yiyue Yin, Guangxian Hu, Hongde Li, Min Li, Xiangjian Luo, Wenbin Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0352812.txt.
Description
Qian Liu and six colleagues identify a gene that seems to hold back an aggressive throat cancer. Their 2026 study concerns nasopharyngeal carcinoma, known for spreading early and answering treatment unevenly. A choline transporter gene, SLC44A4, stood out as switched down in tumours. The team combined public gene datasets, single-cell analysis, patient samples, and laboratory cell lines. High expression of the gene painted a different tumour picture than low expression.
Tumours rich in the gene welcomed more B cells and organised immune structures. In dishes, restoring the gene slowed the cancer cells down. They divided less, migrated less, and invaded less, stalling at the cell cycle's first gate. Restored cells also grew more sensitive to several DNA-damaging drugs, including cisplatin. One standard drug bucked the trend and worked worse. A gene that predicts both immune character and drug response could help doctors personalise treatment for this difficult cancer.
Catalog record
| CREATOR | Qian Liu, Yiyue Yin, Guangxian Hu, Hongde Li, Min Li, Xiangjian Luo, Wenbin Liu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34060 |
| LICENSE | CC_BY |
| RIGHTS | CC BY |
| SOURCE | PLOS |